Skip to main content
. 2019 Aug 30;6:2054358119870540. doi: 10.1177/2054358119870540

Figure 2.

Figure 2.

Funding models for medications of CKD, dialysis, and transplantation patients in participating OECD countries (n = 25).

Note. The survey respondents for Canada (★) selected a “mixed-funding model,” a combination of public and private for the three indicator kidney services. Response from Belgium missing from analysis. CKD = chronic kidney disease; OECD = Organisation for Economic Co-operation and Development.